Brown Derek, Rahman Mohammad, Nana-Sinkam S Patrick
1 Department of Medicine and the Dorothy M. Davis Heart and Lung Research Institute, and.
Ann Am Thorac Soc. 2014 Oct;11(8):1277-85. doi: 10.1513/AnnalsATS.201404-179FR.
Since their initial discovery in the early 1990s, microRNAs have now become the focus of a multitude of lines of investigation ranging from basic biology to translational applications in the clinic. Previously believed to be of no biological relevance, microRNAs regulate processes fundamental to human health and disease. In diseases of the lung, microRNAs have been implicated in developmental programming, as drivers of disease, potential therapeutic targets, and clinical biomarkers; however, several obstacles must be overcome for us to fully realize their potential therapeutic use. Here, we provide for the clinician an overview of microRNA biology in selected diseases of the lung with a focus on their potential clinical application.
自20世纪90年代初首次发现以来,微小RNA如今已成为众多研究领域的焦点,涵盖从基础生物学到临床转化应用。微小RNA以前被认为没有生物学相关性,现在已知其可调节对人类健康和疾病至关重要的过程。在肺部疾病中,微小RNA与发育编程、疾病驱动因素、潜在治疗靶点及临床生物标志物有关;然而,要充分实现其潜在治疗用途,我们必须克服几个障碍。在此,我们为临床医生提供了一份关于特定肺部疾病中微小RNA生物学的概述,重点关注其潜在的临床应用。